首页
探索
nav.journalClub
趋势
更多
Synapse
⌘+K
Synapse
语言
简体中文
简体中文
Ralph K. Lindemann | Synapse
RK
Ralph K. Lindemann
PARP inhibition in cancer therapy
Xenetic Biosciences (United Kingdom)
Share
Follow
Claim This Profile
About
Research focus
PARP inhibition in cancer therapy
Impact
64 pubs · 2,828 cites · h-index 22
Affiliations
Xenetic Biosciences (United Kingdom)
Merck (Germany)
Howard Hughes Medical Institute
See all
Publications